PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells. (Q54688787)
Jump to navigation
Jump to search
scientific article published in January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells. |
scientific article published in January 2010 |
Statements
1 reference
PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells. (English)
1 reference
1 reference
Gunhild M Maelandsmo
1 reference
Mari Kaarbø
1 reference
Oyvind Løveseter Mikkelsen
1 reference
Lene Malerød
1 reference
Su Qu
1 reference
Gulcan Akgul
1 reference
Thomas Halvorsen
1 reference
Fahri Saatcioglu
1 reference
1 January 2010
1 reference
1 reference
32
1 reference
1-2
1 reference
11-27
1 reference
Identifiers
1 reference
1 reference